ivabradine has been researched along with cj-023,423 in 1 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (cj-023,423) | Trials (cj-023,423) | Recent Studies (post-2010) (cj-023,423) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 31 | 9 | 28 |
| Protein | Taxonomy | ivabradine (IC50) | cj-023,423 (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.181 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuseya, S; Ishida, K; Kashihara, T; Kawagishi, H; Kawamata, M; Kiyosawa, K; Nakada, T; Tanaka, S; Yamada, M; Zhang, H | 1 |
1 other study(ies) available for ivabradine and cj-023,423
| Article | Year |
|---|---|
Prostanoid EP4 Receptor-Mediated Augmentation of
Topics: Animals; Dose-Response Relationship, Drug; Ganglia, Spinal; Injections, Spinal; Ivabradine; Male; Membrane Potentials; Neuralgia; Neurons; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E, EP4 Subtype; Sulfonamides | 2019 |